Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
heparinnatrium 1000 IE/ml injektionsvæske, opløsning, 1 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 1000 IE/ml infusionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 5000 IE/ml injektionsvæske, opløsnng, 1 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 5000 IE/ml injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 25.000 IE/ml injektionsvæske, opløsning, 1 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 25.000 IE/ml injektionsvæske, opløsning, 5 ml hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 1000 IE/ml infusionsvæske, opløsning, 10 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 1000 IE/ml infusionsvæske, opløsning, 20 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 25.000 IE/ml injektionsvæske, opløsning, ampul a 0,2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 25.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 50 enheder/5 ml opløsning til forebyggelse af koagulation i venekanyler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 200 enheder/2 ml opløsning til forebyggelse af koagulation i venekanyler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 500 IE/natriumchlorid 0,9 % infusionsvæske, opløsning, flaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 2000 IE/natriumchlorid 0,9 % infusionsvæske, opløsning, flaske a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 10 enheder/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 100 enheder/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 10 enheder/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 100 enheder/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 1000 enheder/ml infusionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 1000 enheder/ml infusionsvæske, opløsning, ampul 1 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
Bovine heparin sodium (substance) |
Is a |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 5000 IE/5 ml injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
heparinnatrium 25.000 IE/5 ml injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
Heparin sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
Product containing heparin sodium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
Bovine heparin sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Heparin sodium |
Inferred relationship |
Some |
|
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 10000 unit/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 10000 unit/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 20000 unit/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 20000 unit/20 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/0.2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/0.2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 125000 unit/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 125000 unit/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 5000 unit/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Heparin sodium |
Inferred relationship |
Some |
1 |
Heparin sodium 5000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |
Heparin sodium 5000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely heparin sodium 25000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Heparin sodium |
Inferred relationship |
Some |
1 |